SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

80,491.29 1,181.28
( 1.49%)

Global Indices

Nasdaq

51,872.69 -1,504.43
(-2.82%)

Dow Jones

7,442.16 -267.46
(-3.47%)

Hang Seng

57,293.47 -3,784.43
(-6.20%)

Nikkei 225

10,776.27 -52.94
(-0.49%)

Forex

USD-INR

94.59 -0.14
(-0.15%)

EUR-INR

106.30 0.31
(0.29%)

GBP-INR

127.42 0.36
(0.28%)

JPY-INR

0.60 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

65.3851573

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

17.15

130.23

EPS(TTM)

Face Value()

Div & Yield %

4.77

1.47

Back

Womancart consolidated net profit rises 43.19% in the September 2026 quarter

Oct 29,2026

Net profit of Womancart rose 43.19% to Rs 3.68 crore in the quarter ended September 2026 as against Rs 2.57 crore during the previous quarter ended September 2025. Sales rose 26.34% to Rs 35.88 crore in the quarter ended September 2026 as against Rs 28.40 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	35.88	28.40	26
OPM %	20.54	21.83	-
PBDT	7.23	5.63	28
PBT	5.80	4.22	37
NP	3.68	2.57	43

80,491.29 1,181.28 ( 1.49%)

51,872.69 -1,504.43 (-2.82%)

7,442.16 -267.46 (-3.47%)

57,293.47 -3,784.43 (-6.20%)

10,776.27 -52.94 (-0.49%)

94.59 -0.14 (-0.15%)

106.30 0.31 (0.29%)

127.42 0.36 (0.28%)

0.60 0.00 (-0.15%)